<code id='AD9B967E12'></code><style id='AD9B967E12'></style>
    • <acronym id='AD9B967E12'></acronym>
      <center id='AD9B967E12'><center id='AD9B967E12'><tfoot id='AD9B967E12'></tfoot></center><abbr id='AD9B967E12'><dir id='AD9B967E12'><tfoot id='AD9B967E12'></tfoot><noframes id='AD9B967E12'>

    • <optgroup id='AD9B967E12'><strike id='AD9B967E12'><sup id='AD9B967E12'></sup></strike><code id='AD9B967E12'></code></optgroup>
        1. <b id='AD9B967E12'><label id='AD9B967E12'><select id='AD9B967E12'><dt id='AD9B967E12'><span id='AD9B967E12'></span></dt></select></label></b><u id='AD9B967E12'></u>
          <i id='AD9B967E12'><strike id='AD9B967E12'><tt id='AD9B967E12'><pre id='AD9B967E12'></pre></tt></strike></i>

          entertainment

          entertainment

          author:entertainment    Page View:59219
          Amylyx founders
          Justin Klee, left, and Joshua Cohen, both co-founders and co-CEO's of Amylyx Pharmaceuticals. Kayana Szymczak for STAT

          The Food and Drug Administration has reversed an internal decision and will now review an experimental treatment for amyotrophic lateral sclerosis — a victory for ALS patients and advocates who have been pressuring regulators to act with more urgency against the fatal, neurodegenerative disease.

          Amylyx Pharmaceuticals, a Cambridge, Mass.-based drug maker, said Wednesday that it will submit an application for its ALS treatment, called AMX0035, “in the coming months.”

          advertisement

          The filing will be based largely on a single clinical trial of AMX0035 completed one year ago that showed a significant slowing of disease progression in patients with ALS. It’s the same study that FDA officials told Amylyx last April was encouraging, but not convincing enough to review for approval on its own. The company was told by FDA staff to conduct another study, gather more positive data, and then file for approval.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          comprehensive

          Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies
          Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

          AdobeSometimes,anappleadayreallyisjustwhatthedoctorordered.Andforthepastseveralyears,organizationsli

          read more
          Rise in cancer among younger people worries and puzzles doctors
          Rise in cancer among younger people worries and puzzles doctors

          Atumorinvasionintoaveininacaseofcolorectalcancer.WikimediaCommonsWhenboththenurseandthe doctorbroked

          read more
          Virginia high school admissions case could be legal follow
          Virginia high school admissions case could be legal follow

          3:24DemonstratorsprotestoutsideoftheSupremeCourtinWashington,Thursday,June29,2023,aftertheSupremeCou

          read more

          Rise in cancer among younger people worries and puzzles doctors

          Atumorinvasionintoaveininacaseofcolorectalcancer.WikimediaCommonsWhenboththenurseandthe doctorbroked